Ligand Pharmaceuticals Incorporated (LGND) NASDAQ

208.95

+4.71(+2.31%)

Updated at March 04 04:00PM

Currency In USD

Valuation

Market Cap3.66B
Enterprise Value3.93B
P/E Ratio32.97
PEG Ratio0.2
Price/Sales Ratio15.27
Price/Book Ratio4.03
Enterprise/Revenue16.3
Enterprise/EBITDA22.3

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin0.46
Operating Margin0.18

Management Effectiveness

Return On Assets0.08
Return On Equity0.14

Income Statement

Revenue268.09M
Revenue/Share13.59
Gross Profit261.5M
EBITDA192.74M
Net Income124.45M
Diluted EPS6.13

Balance Sheet

Total Cash733.52M
Total Cash/Share37.19
Total Debt451.49M
Total Debt/Equity0.44
Current Ratio22.23
Book Value Per Share51.57

Price History

52-Week Change80.44
52-Week High212.49
52-Week Low93.58
Moving Average 50 Days194.31
Moving Average 200 Days165.63

Statistics

Average Volume210,218
Shares Outstanding19.68M
% Held by Institutions106.09

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1603:1000
Last Split DateNovember 02, 2022